LSD1-IN-30

CAS No. 1289575-45-6

LSD1-IN-30( —— )

Catalog No. M37358 CAS No. 1289575-45-6

LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 179 Get Quote
5MG 282 Get Quote
10MG 451 Get Quote
25MG 877 Get Quote
50MG 1408 Get Quote
100MG 2205 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LSD1-IN-30
  • Note
    Research use only, not for human use.
  • Brief Description
    LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.
  • Description
    LSD1-IN-30 (compound 3) is a potent inhibitor of lysine-specific demethylase 1 (LSD1), with the IC50 value of 0.291 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1289575-45-6
  • Formula Weight
    270.28
  • Molecular Formula
    C15H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (369.99 mM; Ultrasonic )
  • SMILES
    C(=N\NC(=O)C1=CC=C(O)C=C1)(\C)/C2=C(O)C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Venkataswamy Sorna, et al. High-Throughput Virtual Screening Identifies Novel N′?(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors. J Med Chem. 2013 Dec 12;56(23):9496-508.?
molnova catalog
related products
  • GSK J4 hydrochloride

    GSK J4 HCl is a cell permeable prodrug of GSK J1, which is the first selective inhibitor of the H3K27 histone demethylase JMJD3 and UTX with IC50 of 60 nM.

  • YF-2

    YF-2 is blood-brain-barrier permeable histone acetyltransferase activator acetylates H3 in the hippocampus ?CBP PCAF and GCN5 with EC50s of 2.75 μM 29.04 μM and 49.31 μM respectively.

  • PFI-90

    PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action.PFI-90 has the potential for the antitumor activity.